Cytokine Release Syndrome and Associated Acute Toxicities in Pediatric Patients Undergoing Immune Effector Cell Therapy or Hematopoietic Cell Transplantation.

Baumeister, Susanne H C; Mohan, Gopi S; Elhaddad, Alaa; Lehmann, Leslie

Baumeister, Susanne H C; Mohan, Gopi S; Elhaddad, Alaa; Lehmann, Leslie.

Afiliación

Baumeister SHC; Boston Children's Hospital, Division of Pediatric Hematology-Oncology, Boston, MA, United States.
Mohan GS; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
Elhaddad A; Harvard Medical School, Boston, MA, United States.
Lehmann L; Boston Children's Hospital, Division of Pediatric Hematology-Oncology, Boston, MA, United States.

Front Oncol ; 12: 841117, 2022.

Article en En | MEDLINE | ID: mdl-35402259

Palabras clave

CAR T cells; blinatumomab; cytokine release syndrome (CRS); haploidentical cell transplantation (Haplo-HCT); immune effector cell associated neurotoxicity syndrome (ICANS); immune effector cells (IEC); pediatric hematopoietic cell transplantation (HCT)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article